Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs

Question 891: Best method of treatment for methyl alcohol poisoning is:

A. Calcium gluconate
B. Ethyl alcohol (Correct Answer)
C. Amphetamines
D. 1% Ammonia

Explanation: ***Ethyl alcohol*** - **Ethanol** (ethyl alcohol) acts as a competitive substrate for **alcohol dehydrogenase**, the enzyme responsible for metabolizing **methanol** into toxic metabolites like formaldehyde and formic acid. - By saturating alcohol dehydrogenase, ethanol prevents the formation of these toxic metabolites, allowing methanol to be excreted unchanged. - **Clinical note**: While **fomepizole** (4-methylpyrazole) is now the preferred first-line antidote when available, **ethanol** remains an effective and widely used alternative, especially in resource-limited settings. - **Administration**: IV ethanol is given to maintain blood ethanol concentration of 100-150 mg/dL. *Calcium gluconate* - **Calcium gluconate** is primarily used to treat **hypocalcemia**, ethylene glycol poisoning (for hypocalcemia), or hydrofluoric acid burns. - It has no role in the management of methyl alcohol poisoning as it does not interfere with the metabolism of methanol or its toxic byproducts. *Amphetamines* - **Amphetamines** are central nervous system stimulants used for conditions like ADHD and narcolepsy. - They have no therapeutic benefit or antidotal properties in the context of methanol poisoning. *1% Ammonia* - **Ammonia** is a strong base and is highly corrosive; it has no medical application as an antidote for methanol poisoning. - Administering ammonia would cause direct tissue damage and exacerbate patient harm due to its toxic and caustic properties.

Question 892: Main function of sodium citrate in ORS?

A. To increase absorption of glucose by cotransport
B. To correct electrolyte imbalance
C. To correct Acidosis (Correct Answer)
D. To correct dehydration

Explanation: ***To correct Acidosis*** - **Sodium citrate** provides a source of **bicarbonate** precursor, which helps to correct the **metabolic acidosis** often associated with severe dehydration and diarrhea. - In the body, citrate is metabolized into bicarbonate, raising the blood pH and counteracting the effects of acidosis. *To increase absorption of glucose by cotransport* - The absorption of glucose and sodium is coupled, meaning the presence of **sodium enhances glucose absorption** through the **SGLT1 cotransporter**. - While sodium is essential for glucose absorption, **citrate's primary role is not this direct cotransport mechanism**. *To correct electrolyte imbalance* - ORS formulations contain various electrolytes like **sodium chloride** and **potassium chloride** to rectify electrolyte imbalances caused by diarrhea. - While sodium citrate contributes to sodium levels, its specific function goes beyond just general electrolyte correction to address the **acid-base balance**. *To correct dehydration* - The overall purpose of ORS is to **rehydrate the patient** by providing fluids and electrolytes, which helps restore circulating volume. - While citrate is a component of ORS, **rehydration also depends on the water and other salts** present in the solution, not solely on citrate.

Question 893: Acetaminophen [Paracetamol] induced liver toxicity is due to which metabolite?

A. Co-Q
B. Cytochrome 'C'
C. NAPQI (Correct Answer)
D. N-acetylcysteine

Explanation: ***NAPQI*** - **N-acetyl-p-benzoquinone imine (NAPQI)** is a highly reactive and toxic metabolite produced during acetaminophen metabolism, especially in overdose situations [1, 3]. - When glutathione stores are depleted due to excessive NAPQI formation, this metabolite covalently binds to hepatic macromolecules, causing **hepatocellular damage and necrosis** [1, 3].*N-acetylcysteine* - **N-acetylcysteine (NAC)** is the antidote for acetaminophen overdose, not the toxic metabolite itself [2, 3]. - NAC works by replenishing hepatic **glutathione stores**, which helps detoxify NAPQI and prevent liver injury [2, 3].*Co-Q* - **Coenzyme Q10 (CoQ10)** is an endogenous antioxidant and electron carrier in the mitochondrial respiratory chain. - It is not a metabolite of acetaminophen and plays no direct role in acetaminophen-induced liver toxicity.*Cytochrome 'C'* - **Cytochrome c** is a protein involved in the electron transport chain in mitochondria and plays a critical role in apoptosis. - While cellular damage from NAPQI can eventually lead to cytochrome c release and apoptosis, cytochrome c itself is not a metabolite of acetaminophen or the direct cause of toxicity.

Question 894: Permission from DCGI [Drug controller general, India] is needed before which phase of drug trial?

A. Phase 1
B. Phase 2
C. Phase 3 (Correct Answer)
D. Phase 4

Explanation: ***Phase 3*** - Permission from the **DCGI (Drug Controller General of India)** is mandatory before initiating **Phase 3** clinical trials as per **Schedule Y** of the Drugs and Cosmetics Rules. - Phase 3 trials involve **large-scale studies in Indian patients** to establish efficacy and safety in the target population, requiring explicit regulatory approval. - This is the critical regulatory checkpoint where DCGI evaluates the Phase 1 and 2 data before allowing widespread testing in Indian subjects. *Phase 1* - Phase 1 trials can be conducted after approval from the **Institutional Ethics Committee (IEC)** without requiring prior DCGI permission. - These trials in healthy volunteers focus on safety, pharmacokinetics, and dose-ranging studies. - DCGI is informed but explicit permission is not mandatory at this stage. *Phase 2* - Phase 2 trials also proceed with **IEC approval** and do not require prior DCGI permission. - These trials evaluate therapeutic efficacy and dose determination in a limited number of patients. - Results from Phase 2 are submitted to DCGI when seeking Phase 3 approval. *Phase 4* - Phase 4 trials are **post-marketing surveillance** studies conducted after drug approval. - These are conducted under the Post-Marketing Surveillance (PMS) framework. - While regulatory oversight exists, these are not pre-market trials requiring permission to initiate.

Question 895: Which of the following is not a known side effect of amiodarone?

A. Peripheral neuropathy
B. Hyperthyroidism
C. Hyperglycemia (Correct Answer)
D. Skin discoloration

Explanation: ***Hyperglycemia*** - **Hyperglycemia** is generally **not recognized** as a direct or common side effect of amiodarone. - Amiodarone's primary action is on cardiac ion channels, and its metabolic effects typically involve thyroid function, not glucose regulation. *Hyperthyroidism* - Amiodarone contains **iodine**, which can induce **thyroid dysfunction**, including both hypo- and hyperthyroidism. - **Amiodarone-induced hyperthyroidism (AIH)** can occur due to increased thyroid hormone synthesis or destructive thyroiditis. *Peripheral neuropathy* - **Neurological side effects**, including **peripheral neuropathy**, are known to occur with chronic amiodarone use. - Symptoms often include **paresthesias**, weakness, and sensory loss in the extremities. *Skin discoloration* - Prolonged use of amiodarone can lead to **bluish-gray skin discoloration**, particularly in sun-exposed areas. - This is due to the **accumulation of amiodarone** and its metabolites in the skin.

Question 896: Which of the following is a primary use of Levamisole?

A. Immunostimulant
B. Antihelminthic (Correct Answer)
C. None of the options
D. Immunomodulator

Explanation: ***Antihelminthic*** - Levamisole is **primarily classified as an antihelminthic drug**, used to treat parasitic worm infections. - It acts as a **nicotinic receptor agonist** in nematodes, causing spastic paralysis of the worms, leading to their expulsion. - It was historically used in humans for treating ascariasis and hookworm infections, and is still used in **veterinary medicine** for deworming livestock. - This is its **primary pharmacological classification** in standard medical textbooks. *Immunomodulator* - Levamisole does have **immunomodulatory properties** that were discovered secondary to its antihelminthic use. - It was used as **adjuvant therapy in colon cancer** (with 5-FU) to enhance immune response. - However, this is a **secondary use**, not its primary classification, and has been largely discontinued due to severe side effects like agranulocytosis. *Immunostimulant* - While levamisole can stimulate certain aspects of cell-mediated immunity, this overlaps with its immunomodulatory effects. - This is **not its primary pharmacological classification** - it remains primarily an antihelminthic agent. *None of the options* - This is incorrect because **antihelminthic** is clearly the primary and correct classification of levamisole in pharmacology. - Its antihelminthic action was its original and primary therapeutic application.

Question 897: All of the following are known adverse effects of thalidomide, except:

A. DVT
B. Neuropathy
C. Teratogenicity
D. Diarrhoea (Correct Answer)

Explanation: ***Diarrhoea*** - **Diarrhoea** is generally *not* considered a common or significant adverse effect of thalidomide. Constipation is more frequently reported. - While individual reactions vary, thalidomide's primary adverse effect profile does not typically include diarrhoea. *Teratogenicity* - **Teratogenicity** is the most notorious adverse effect of thalidomide, causing severe birth defects like **phocomelia** (shortened or absent limbs) in infants exposed during pregnancy. - Due to this, stringent **risk evaluation and mitigation strategies (REMS)** are in place for thalidomide use. *DVT* - Thalidomide is known to increase the risk of **venous thromboembolism (VTE)**, including **deep vein thrombosis (DVT)** and pulmonary embolism, especially in patients with multiple myeloma. - Prophylactic anticoagulation is often recommended for patients receiving thalidomide, particularly in combination with corticosteroids. *Neuropathy* - **Peripheral neuropathy** is a common and dose-limiting adverse effect of thalidomide, often presenting as numbness, tingling, and pain in the hands and feet. - It can be progressive and potentially irreversible, requiring careful monitoring and dose adjustments.

Question 898: Interstitial nephritis is associated with all of the following medications except:

A. INH (Correct Answer)
B. Diuretics
C. Allopurinol
D. Beta-lactam antibiotics

Explanation: ***INH*** - **Isoniazid (INH)** is primarily associated with **hepatotoxicity** (liver damage) and **peripheral neuropathy**, not typically interstitial nephritis. - While many drugs can rarely cause various adverse effects, INH is not a recognized common cause of **drug-induced interstitial nephritis**. *Beta-lactam antibiotics* - **Beta-lactam antibiotics**, including penicillins and cephalosporins, are among the most common causes of **drug-induced acute interstitial nephritis (AIN)**. - AIN is an **allergic hypersensitivity reaction** characterized by inflammation of the kidney's tubules and interstitium. *Diuretics* - Certain **diuretics**, particularly **thiazide diuretics** and **loop diuretics**, have been implicated in causing **acute interstitial nephritis**. - The mechanism is thought to be an **allergic or hypersensitivity reaction** within the renal tubules and interstitium. *Allopurinol* - **Allopurinol**, used to treat gout and hyperuricemia, is a known cause of **drug-induced acute interstitial nephritis**. - Renal involvement with allopurinol can range from mild tubular dysfunction to severe **acute kidney injury** due to AIN.

Question 899: Alkaline diuresis in drug poisoning is not done in?

A. Aspirin
B. Morphine (Correct Answer)
C. Phenobarbitone
D. Methotrexate

Explanation: ***Morphine*** - **Morphine** is an **alkaline drug**, so its elimination is actually enhanced by **acidification of the urine**, not alkalinization. - Alkaline diuresis would decrease the ionization of morphine in the renal tubules, leading to **increased reabsorption** and reduced excretion. *Aspirin* - **Aspirin (acetylsalicylic acid)** is an **acidic drug**, and **alkaline diuresis** is effective in increasing its excretion by trapping the ionized form in the renal tubules. - This process prevents reabsorption and promotes clearance, which is a standard treatment for aspirin overdose. *Methotrexate* - **Methotrexate** is a **weak organic acid**, and **alkaline diuresis** is crucial in reducing its toxicity, especially in high-dose therapy. - By increasing urine pH, the renal elimination of methotrexate is significantly enhanced, preventing kidney damage and systemic accumulation. *Phenobarbitone* - **Phenobarbitone** is a **weak acid**, and **alkaline diuresis** is a well-established method to increase its renal excretion in cases of overdose. - Alkalinization of the urine promotes the ionization of phenobarbitone, reducing its reabsorption by the renal tubules and accelerating its elimination.

Question 900: Which of the following conditions is not associated with an increased risk of neuropathy caused by Isoniazid (INH)?

A. Uremia
B. Diabetes mellitus
C. Poor nutrition
D. Hyperthyroidism (Correct Answer)

Explanation: ***Hyperthyroidism*** - **Hyperthyroidism** is not typically associated with an increased risk of isoniazid-induced neuropathy. The neuropathy due to INH is primarily linked to **pyridoxine (vitamin B6) deficiency**. - While hyperthyroidism can cause its own set of neurological symptoms, it does not directly impair pyridoxine metabolism or exacerbate INH's neurotoxic effects. *Uremia* - **Uremia** (renal failure) can increase the risk of INH-induced neuropathy due to impaired drug excretion, leading to higher plasma concentrations of INH and its metabolites. - Patients with uremia often have compromised nutritional status and may experience vitamin deficiencies, further contributing to pyridoxine depletion. *Diabetes mellitus* - **Diabetes mellitus** is a significant risk factor for INH-induced neuropathy because it is an independent cause of **peripheral neuropathy** itself, making patients more susceptible to additional nerve damage. - Diabetic patients may also have altered pyridoxine metabolism or suboptimal nutritional intake, predisposing them to INH toxicity. *Poor nutrition* - **Poor nutrition**, particularly malabsorption or inadequate dietary intake, directly contributes to **pyridoxine (vitamin B6) deficiency**. - Isoniazid's mechanism of neurotoxicity involves interfering with pyridoxine metabolism, so pre-existing deficiency significantly increases the risk of neuropathy.

Practice by Chapter

Principles of Clinical Pharmacology

Practice Questions

Therapeutic Drug Monitoring

Practice Questions

Drug Toxicity and Overdose

Practice Questions

Antidotes and Their Applications

Practice Questions

Management of Drug Poisoning

Practice Questions

Drug-Induced Liver Injury

Practice Questions

Drug-Induced Kidney Injury

Practice Questions

Drug-Induced Blood Dyscrasias

Practice Questions

Drug-Induced QT Prolongation

Practice Questions

Pharmacovigilance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free